JOURNAL OF CLINICAL ONCOLOGY

Rivista

Codice:

E091050

ISSN:

0732-183X

Dati Generali

Pubblicazioni (90)

A plethora of therapeutic opportunities for elderly patients with cancer: A nontrivial choice

Articolo

A randomized trial for the treatment of high-grade soft-tissue sarcomas of the extremities: preliminary observation.

Articolo

Abiraterone Acetate in Patients With Castration-Resistant, Androgen Receptor-Expressing Salivary Gland Cancer: A Phase II Trial

Articolo

Adjuvant therapy in patients with adrenocortical carcinoma: a position of an international panel.

Articolo

Association between salivary cytokine levels and chemoradiotherapy-induced toxicities in head and neck cancer patients

Articolo

Bi-weekly fixed dose of gemcitabine (GEM) plus 24 hours infusion of cisplatin (CDDP) in advanced/metastastic pancreatic cancer (APC) patients: A phase II study

Abstract

Bone Mineral Density and FRAX Score May Not Predict Fracture Risk in Patients With Cancer Undergoing Hormone Deprivation Therapies

Articolo

CXCR4/SDF-1 expression in early breast cancer (BC) is not influenced by circulating estrogens serum levels

Abstract

Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial

Articolo

Changes in body composition after androgen deprivation therapy (ADT) in prostate cancer patients. Relationship with disease outcome

Contributo in Atti di convegno

Changes in bone mineral density after adjuvant aromatase inhibitors and fracture risk in breast cancer patients

Articolo

Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.

Articolo

Circadian rhythm of bone turnover markers in breast cancer patients with bone metastases and in control subjects

Contributo in Atti di convegno

Circadian rhythm of breakthrough cancer pain.

Contributo in Atti di convegno

Circulating pretreatment Epstein Barr Virus DNA quantification as a prognostic factor in nasopharyngeal cancer patients in a non endemic area

Articolo

Clinical Relevance of of Cyclin D1 Protein Overexpression in Laryngeal Squamous Cell Carcinoma.

Articolo

Clinical relevance of expression of the CIP/KIP cell-cycle inhibitors p21 and p27 in laryngeal cancer.

Articolo

Co-isolation and analysis of extracellular vesicle (EV)-associated DNA and cell free DNA (cfDNA) to improve the diagnostic and prognostic value of circulating BRAF V600E in metastatic melanoma patients

Abstract

Comparison between patients with Philadelphia-positive chronic phase chronic myeloid leukemia who obtained a complete cytogenetic response within 1 year of imatinib therapy and those who achieved such a response after 12 months of treatment.

Articolo

Could the efficacy of docetaxel in prostate cancer patients be potentiated by concomitant high-dose calcitriol administration?

Articolo

Definition, Diagnosis, and Management of Intravascular Large B-Cell Lymphoma: Proposals and Perspectives From an International Consensus Meeting.

Articolo

Detecting characteristics of nodal invasion in advanced squamocellular oral cavity cancer through a gene expression profile on primary tumor

Articolo

Detection of serum proteomic profile predictive for epidermal growth factor receptor tyrosine kinase inihibitors (EGFR-TKIs) in 1st line chemotherapy responders

Abstract

Differential impact of cisplatin dose intensity on human papillomavirus (HPV)-related (+) and HPV-unrelated (-) locoregionally advanced head and neck squamous cell carcinoma (LAHNSCC)

Articolo

Effect of zoledronic acid (Z) treatment based on serum parathyroid hormone (PTH) levels in patients (pts) with malignant bone disease.

Contributo in Atti di convegno

Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study

Articolo

Extended-field radiotherapy is superior to MOPP chemotherapy for the treatment of pathologic stage I-II A Hodgkin's disease: 8-year update of an Italian prospective randomized study

Articolo

External validation of a biomarker-based preoperative nomogram predicts biochemical recurrence after radical prostatectomy

Articolo

Family physicians could help in predicting life expectancy without prostate cancer - Reply

Articolo

Folate in head and neck squamous cell cancer chemoprevention: Purposely left out?

Articolo

Gastric cancer with synchronous hepatic metastases: A multicentric Italian survey.

Abstract

Gemcitabine (Gem) plus celecoxib in advanced pancreatic carcinoma: a phase II study

Abstract

Gene expression profiling uncovers molecular classifiers for therecognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms

Articolo

Gonadal function in male patients with metastatic renal cell cancer treated with sunitinib: Effects of testosterone replacement on quality of life.

Abstract

Health and economic outcomes of two different follow up strategies in effectively cured advanced head and neck cancer patients

Articolo

Health care-associated infections (HAIs) in head and neck carcinoma (HNC) patients treated with chemotherapy (CT) and/or radiotherapy (RT)

Articolo

High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma

Articolo

How Many Therapeutic Options Are There for Recurrent or Metastatic Salivary Duct Carcinoma?

Articolo

Identification of a gene expression profile associated with progression-free survival (PFS) in relapsed or metastatic (RM) head and neck squamous cell cancer (HNSCC) patients (pts) treated with first-line cetuximab and platinum therapy

Articolo

Impact of Adjuvant Radiotherapy on Survival of Patients With Node-Positive Prostate Cancer

Articolo

Increased antiresorptive activity of zoledronic acid (Z) administered in the night as compared to morning administration in breast cancer (BC) patients with bone metastases.

Contributo in Atti di convegno

Is pathologic complete response a valid surrogate parameter of treatment efficacy in HER2 positive breast cancer patients undergoing primary chemotherapy plus trastuzamab?

Articolo

Is restoring platinum sensitivity the best goal for cetuximab in recurrent/metastatic nasopharyngeal cancer? [15]

Articolo

Is time to first skeletal-related event the best primary end point in the assessment of bisphosphonate efficacy in patients with castration-sensitive prostate cancer?

Articolo

Lenvatinib in Patients With Advanced Grade 1/2 Pancreatic and Gastrointestinal Neuroendocrine Tumors: Results of the Phase II TALENT Trial (GETNE1509)

Articolo

Lonidamine significantly increases the activity of epirubicin in patients with advanced breast cancer: results from a multicenter prospective randomized trial.

Articolo

Lymphovascular Invasion Predicts Clinical Outcomes in Patients With Node-Negative Upper Tract Urothelial Carcinoma

Articolo

Meta-analysis: Risk of congestive heart failure (CHF) in selected targeted agents

Articolo

Modulation of Fluorouracil by Leucovorin in Patients with Advanced Colorectal Cancer: Evidence in Terms of Response Rate

Articolo

Monitoring treatment and survival in chronic myeloid leukemia.

Articolo

Needs in breast cancer patients (pts) during chemotherapy: Customer satisfaction evaluation

Abstract

Neurotoxicity in older colorectal patients with diabetes treated with oxaliplatin schedule: Our experience

Abstract

Oligometastatic prostate cancer patients stratification: A molecular signature identified by liquid biopsy

Abstract

Osteonecrosis of the jaw after zoledronic acid and denosumab treatment.

Articolo

Palifermin in Prevention of Head and Neck Cancer Radiation-Induced Mucositis: Not Yet a Definitive Word on Safety and Efficacy Profile

Articolo

Pathologic Complete Response As a Potential Surrogate for the Clinical Outcome in Patients With Breast Cancer After Neoadjuvant Therapy: A Meta-Regression of 29 Randomized Prospective Studies.

Articolo

Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group

Articolo

Personalized - Not omitted - Radiation oncology for breast cancer

Articolo

Phase II study of sunitinib and irinotecan in patients with recurrent high-grade glioma (HGG)

Abstract

Phase II study of vinorelbine with protracted fluorouracil infusion as a second- or third-line approach for advanced breast cancer patients previously treated with anthracyclines

Articolo

Phase III trial of observation versus six courses of paclitaxel in patients with advanced epithelial ovarian cancer in complete response after six courses of paclitaxel/platinum-based chemotherapy: final results of the After-6 protocol 1.

Articolo

Phosphorylated ERÎ±, HIF-1Î±, and MAPK signaling as predictors of primary endocrine treatment response and resistance in patients with breast cancer

Articolo

Post-transplantation cyclophosphamide-based haploidentical transplantation as alternative to matched sibling or unrelated donor transplantation for hodgkin lymphoma: A registry study of the lymphoma working party of the european society for blood and marrow transplantation

Articolo

Prediction of TP53 status for primary cisplatin, fluorouracil, and leucovorin chemotherapy in ethmoid sinus intestinal-type adenocarcinoma

Articolo

Predictive factors for skeletal complications in prostate cancer patients with hormone refractory disease

Contributo in Atti di convegno

Primary resistances to EGFR inhibitors (EGFRi) in HPV-positive and -negative oropharyngeal squamous cell carcinoma (OSCC)

Articolo

Prognostic role of PI3KCA and TP53 in HPV-negative oropharyngeal cancers (OPCs)

Articolo

Pulmonary calciphylaxis and metastatic calcification with acute respiratory failure in multiple myeloma.

Articolo

Radiation dose-response relationship for risk of coronary heart disease in survivors of hodgkin lymphoma

Articolo

Radiofrequency ablation versus stereotactic body radiotherapy for hepatocellular carcinoma: No way out without a randomized trial?

Articolo

Randomized dose-ranging trial of tamoxifen at low doses in hormone replacement therapy users.

Articolo

Randomized phase II trial of letrozole and letrozole plus low-dose metronomic oral cyclophosphamide as primary systemic treatment in elderly breast cancer patients

Articolo

Reversible pancytopenia caused by oral letrozole assumption in a patient with recurrent breast cancer.

Articolo

Risk of Acute Myeloid Leukemia and Myelodysplastic Syndrome in Trials of Adjuvant Epirubicin for Early Breast Cancer: Correlation With Doses of Epirubicin and Cyclophosphamide.

Articolo

Serum vitamin D and prostate cancer prognosis: The story continues

Articolo

Should Adjuvant Weekly Paclitaxel Be Considered Less Efficacious Than Anthracyclines Plus Cyclophosphamide for Lower Risk Patients With Early-Stage Breast Cancer?

Articolo

Single nucleotide polymorphisms and clinical outcome in biliary tract carcinoma treated with epirubicin, cisplatin and capecitabine

Abstract

Sorafenib in recurrent and/or metastatic salivary gland carcinomas (RMSGCs): An investigator-initiated phase II trial (NCT01703455)

Articolo

TP53 Mutations and Pathologic Complete Response to Neoadjuvant Cisplatin and Fluorouracil Chemotherapy in Resected Oral Cavity Squamous Cell Carcinoma

Articolo

TPF induction chemotherapy (CT) followed by concomitant cisplatin/radiotherapy (cCTRT) in locally advanced nasopharyngeal cancer (LANPC)

Articolo

The onset of skeletal complications in hormone refractory prostate cancer patients is not influenced by the duration of androgen deprivation therapy

Contributo in Atti di convegno

The role of hemoglobin level in predicting the response to first-line chemotherapy in advanced colorectal cancer (ACC)

Contributo in Atti di convegno

Time to progression in metastatic breast cancer patients treated with epirubicin is not improved by the addition of either cisplatin or lonidamine: final results of a phase III study with a factorial design.

Articolo

Topoisomerase II alpha (TopoIIa) and MAPtau: Potential predictive markers of response in locally advanced breast cancer (LABC) treated with epirubicin and docetaxel (ET) in neoadjuvant setting

Articolo

Toxicity of stereotactic body radiation therapy versus intensity-modulated radiation therapy for prostate cancer: A potential comparison bias

Articolo

Transformation of prostate adenocarcinoma into small-cell neuroendocrine cancer under androgen deprivation therapy: Much is achieved but more information is needed

Articolo

Treatment-associated mortality in head and neck cancer receiving chemotherapy and radiation: Meta-analysis of published trials

Articolo

Upregulation of RAS pathway to predict the risk of distant metastases in HPV plus oropharynx cancer

Articolo

When should everolimus be administered in the natural history of pancreatic neuroendocrine tumors?

Articolo

mRNA Expression Signature of Gleason Grade Predicts Lethal Prostate Cancer

Articolo

No Results Found

JOURNAL OF CLINICAL ONCOLOGY

Dati Generali

Pubblicazioni (90)